Cytec to Close Dutch Plant as Part of Restructuring Program

Cytec Industries announced today a restructuring of its polymer additives product line. The restructuring actions include permanently shutting down the manufacturing operations for two older technology polymer additive light stabilizer products produced at the manufacturing facility in Botlek, the Netherlands. Production of CYASORB® UV-5411 light stabilizer will be consolidated at Cytec’s Willow Island, West Virginia facility. The remaining production of CYASORB® UV-1084 light stabilizer is expected to cease by the end of the third quarter and Cytec will exit this product line. The shutdown of the polymer additive production in Botlek included a full review of the support and commercial infrastructure at the site and as a result of these actions approximately 65 positions will be eliminated. An estimated pre-tax restructuring charge of $21.7 million will be included in our full year 2006 results of which $13.7 million relates to a non-cash write-off of polymer additive assets at our Botlek site with the majority of the balance being severance related.

David Lilley, Chairman, President and Chief Executive Officer commented, “Market conditions for these two products have continued to deteriorate. Our manufacturing people in Botlek have done an excellent job in improving operations but even after those efforts the products are not profitable. Our commercial and technology staff have done some tremendous work in growing the technologically differentiated products of polymer additives and this restructuring will help us focus even more effort in replacing the older technology with these important new products. We believe these actions will improve the earnings of the polymer additives product line and enhance the competitive position of the Botlek site which will continue to produce water treatment chemicals, acrylamide, CYREZ® and specialty additives. We expect these actions to be accretive to earnings per share in 2007.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.